Author Archives: Rachelle Alpern
UNC School of Medicine researchers Drs. Mark Zylka and Ben Philpot are partnering with AskBio to develop a gene therapy treatment for Angelman syndrome, a rare neurogenetic disorder with no cure. Preclinical evidence has shown that gene therapy may improve motor outcomes and reduce seizures, potentially transforming the lives of people living with condition.
The NIH National Human Genome Research Insititute’s Genomic Medicine Group named UNC Department of Medicine and UNC Eshelman School of Pharmacy’s study as one of the top 10 advances in genomic medicine in 2019. This study found that continuous use of clopidogrel in patients who are genetic “non-responders” is associated with adverse outcomes.
Dr. Gaorav Gupta and Dr. Bhisham Chera from UNC Lineberger Comprehensive Cancer Center led the study which found this blood test to be 99% accurate in detecting HPV-linked oropharyngeal cancer. This blood test provides a non-invasive option to monitor patients after finishing cancer treatment.
Dr. Matthew Hirsch, assistant professor in the UNC Department of Ophthalmology and member of UNC’s Gene Therapy Center, leads the pioneering research of utilizing gene therapy to prevent vision loss for patients with MPS I. His new method, which will soon be tested in a clinical trial, brings the potential of restoring sight to patients … Read more
Palforzia is a newly approved medication that mitigates the consequences of accidental exposure to peanuts. Dr. Wesley Burks and Dr. Edwin Kim, members of the UNC Children’s Research Institute, were key partners in spearheading the research that led to the development of this groundbreaking treatment.
Antonio Amelio, PhD, researcher at UNC’s Lineberger Comprehensive Cancer Center, is part of a team that has created a new self-illuminating protein complex which removes the need for an external light source in optogenetics. This new discovery has the potential to give researchers better insight into cancer cell behaviors and future treatments.